Viewing Study NCT05552651


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-02-20 @ 3:27 AM
Study NCT ID: NCT05552651
Status: UNKNOWN
Last Update Posted: 2022-09-23
First Post: 2022-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Sponsor: Tao Jiang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module